Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-18-008143
Filing Date
2018-02-23
Accepted
2018-02-23 19:07:17
Documents
1
Period of Report
2018-02-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 9402
  Complete submission text file 0001127602-18-008143.txt   10754
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Issuer) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY CA 94404
Business Address
MILLIGAN JOHN F (Reporting) CIK: 0001191589 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19731 | Film No.: 18638170